Metraipolis › archive › dc_bfaa5c8ceca8

A systematic evaluation of double-expressor lymphoma: prognostic impact, determinants of outcome, and comparative efficacy and safety of novel therapies — Europe PMC PMID:42255243

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42255243
DOI: 10.3389/fonc.2026.1823300
License (as archived): solo-consultazione
Archived: 2026-11-01T11:10:38.222Z
SHA-256 of the archived text: ec2d81a6a9c7cef5c7e0bce44b39a1a8b314748f3144eaa3f23b16413c4ac6a3
Stable URL of this page: https://metraipolis.com/documento/dc_bfaa5c8ceca8

How to cite

A systematic evaluation of double-expressor lymphoma: prognostic impact, determinants of outcome, and comparative efficacy and safety of novel therapies — Europe PMC PMID:42255243 — Europe PMC (en), https://europepmc.org/article/MED/42255243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfaa5c8ceca8 (Metraipolis archive dc_bfaa5c8ceca8, sha256 ec2d81a6a9c7cef5c7e0bce44b39a1a8b314748f3144eaa3f23b16413c4ac6a3)

BibTeX

@misc{dcbfaa5c8ceca8,
  title = {A systematic evaluation of double-expressor lymphoma: prognostic impact, determinants of outcome, and comparative efficacy and safety of novel therapies — Europe PMC PMID:42255243},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42255243},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfaa5c8ceca8; sha256 ec2d81a6a9c7cef5c7e0bce44b39a1a8b314748f3144eaa3f23b16413c4ac6a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42255243. Agents can read the archived copy with the MCP tool read_document.